The risk associated with hyperoncotic colloids in patients with shock
Authors:
- Frédérique SchortgenFSFrédérique Schortgen
- for the CRYCO Study GroupFGfor the CRYCO Study Group
- 7 August 2008
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 34 (12) , 2157-2168
Abstract
Crystalloids, artificial and natural colloids have been opposed as representing different strategies for shock resuscitation, but it may be relevant to distinguish fluids based on their oncotic characteristics. This study assessed the risk of renal adverse events in patients with shock resuscitated using hypooncotic colloids, artificial hyperoncotic colloids, hyperoncotic albumin or crystalloids, according to physician’s choice. International prospective cohort study including 1,013 ICU patients needing fluid resuscitation for shock. Patients suffering from cirrhosis or receiving plasma were excluded. Influence of different types of colloids and crystalloids on the occurrence of renal events (twofold increase in creatinine or need for dialysis) and mortality was assessed using multivariate analyses and propensity score. Statistical adjustment was based on severity at the time of resuscitation, risks factor for renal failure, and on variables influencing physicians’ preferences regarding fluids. A renal event occurred in 17% of patients. After adjustment on potential confounding factors and on propensity score for the use of hyperoncotic colloids, the use of artificial hyperoncotic colloids [OR: 2.48 (1.24–4.97)] and hyperoncotic albumin [OR: 5.99 (2.75–13.08)] was significantly associated with occurrence of renal event. Overall ICU mortality was 27.1%. The use of hyperoncotic albumin was associated with an increased risk of ICU death [OR: 2.79 (1.42–5.47)]. This study suggests that harmful effects on renal function and outcome of hyperoncotic colloids may exist. Although an improper usage of these compounds and confounding factors cannot be ruled out, their use should be regarded with caution, especially because suitable alternatives exist.Keywords
This publication has 55 references indexed in Scilit:
- Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study*Critical Care Medicine, 2006
- Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised studyThe Lancet, 2001
- Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipientsThe Lancet, 1996
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- Renal failure associated with unrecognized hyperoncotic states after pediatric heart surgeryIntensive Care Medicine, 1996
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Acute Lowering of Plasma Oncotic Pressure Increases Filtration Fraction and Sodium Excretion in Conscious SheepKidney and Blood Pressure Research, 1992
- AIDS-Related Kaposi's Sarcoma in New York City in 1977New England Journal of Medicine, 1988
- Acute Renal Failure Associated with Elevated Plasma Oncotic PressureNew England Journal of Medicine, 1987
- Reducing Bias in Observational Studies Using Subclassification on the Propensity ScoreJournal of the American Statistical Association, 1984